Pick the best stocks and maximize your portfolio:
- Discover top-rated stocks from highly ranked analysts with Analyst Top Stocks!
- Easily identify outperforming stocks and invest smarter with Top Smart Score Stocks
The latest update is out from Alpha Tau Medical Ltd ( (DRTS) ).
Alpha Tau Medical Ltd has appointed Maya Netser to its Board of Directors, following the completion of Meir Jakobsohn’s term, who will remain an advisor. The appointment comes as the company is expanding its strategic focus into treatments for internal organs, with Netser bringing extensive experience in corporate leadership and technology to support Alpha Tau’s mission in advancing cancer care.
More about Alpha Tau Medical Ltd
Founded in 2016, Alpha Tau Medical Ltd is an Israeli oncology therapeutics company focusing on the research, development, and potential commercialization of the Alpha DaRT technology for the treatment of solid tumors. The technology, initially developed by professors from Tel Aviv University, aims to provide highly potent and targeted alpha-irradiation to destroy tumors while sparing healthy tissues.
YTD Price Performance: 2.99%
Average Trading Volume: 35,375
Technical Sentiment Consensus Rating: Sell
Current Market Cap: $216.8M
See more data about DRTS stock on TipRanks’ Stock Analysis page.
